Kim DH, Lim ST, Kim HR, Kang EJ, et al. Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study. Oral Oncol 2024;151:106739.
PMID: 38458039